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Abstract
Alginate cell-based therapy requires further development focused on clinical application. To assess engraftment, risk of
mutations and therapeutic benefit studies should be performed in an appropriate non-human primate model, such as the
common marmoset (Callithrix jacchus). In this work we encapsulated amnion derived multipotent stromal cells (MSCs) from
Callithrix jacchus in defined size alginate beads using a high voltage technique. Our results indicate that i) alginate-cell
mixing procedure and cell concentration do not affect the diameter of alginate beads, ii) encapsulation of high cell numbers
(up to 106106 cells/ml) can be performed in alginate beads utilizing high voltage and iii) high voltage (15–30 kV) does not
alter the viability, proliferation and differentiation capacity of MSCs post-encapsulation compared with alginate
encapsulated cells produced by the traditional air-flow method. The consistent results were obtained over the period of
7 days of encapsulated MSCs culture and after cryopreservation utilizing a slow cooling procedure (1 K/min). The results of
this work show that high voltage encapsulation can further be maximized to develop cell-based therapies with alginate
beads in a non-human primate model towards human application.
Citation: Gryshkov O, Pogozhykh D, Hofmann N, Pogozhykh O, Mueller T, et al. (2014) Encapsulating Non-Human Primate Multipotent Stromal Cells in Alginate
via High Voltage for Cell-Based Therapies and Cryopreservation. PLoS ONE 9(9): e107911. doi:10.1371/journal.pone.0107911
Editor: Giovanni Camussi, University of Torino, Italy
Received May 26, 2014; Accepted August 21, 2014; Published September 26, 2014
Copyright:  2014 Gryshkov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG - German Research Foundation, http://www.dfg.de/) by the Cluster of Excellence
REBIRTH (DFG EXC 62/1, http://www.rebirth-hannover.de) and Open Access Publishing Fund of Leibniz Universitaet Hannover. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: gryshkov@imp.uni-hannover.de
Introduction
Cell-based therapies are under development to treat a wide
range of acute and chronic diseases. To date, they have been
successfully applied in treatments of the central and peripheral
nervous system [1], bone and cartilage regeneration, hepatic
fibrosis and cardiac insufficiencies [2,3]. The main challenge in
such allogenic therapies is the suppression of the host immune
system prior to and during the treatment. In addition, drug-based
immune system suppression has many side effects for the patient
[4]. One strategy to avoid harmful immunosupression of the host is
the suppression of the major histocompatibility complex I (MHC
I), a major obstacle in transplantation, in the transplanted cells by
small hairpin RNA (shRNA) method [5]. Alternatively, cells can
be encapsulated into polymer matrices with semi-permeable
properties; these shield transplanted cells from immune responses,
while allowing controlled release of drugs and cellular products
[6]. Interestingly, most matrices mimic the extra-cellular matrix
and therefore provide the cells with a niche-like environment
during post-transplantation (Figure 1A).
Alginate is known to be a linear block co-polymer containing
sequences of (1–4)-linked b-D-mannuronate (M-residue), its C-5
epimer a-L-guluronate (G-residue) and alternating M and G
residues (MG-residues). It can be produced from brown algae and
bacteria. However, alginate extracted from different sources has
variable properties and alginate beads produced by a range of
cross-linking methods display a wide range of final biological and
physical properties, affecting the mechanical properties of a bead
and cell response in-vitro and in-vivo [7]. The features of cross-
linking include: ionic cross-linking with divalent cations, such as
barium and calcium, that provides living cells with a niche-like
environment and ease of gelation, forming so called egg-box
structure [8]; whereas covalent cross-linking with polyethylene
glycol induced by laser irradiation enhances the degradation rate
facilitating a more homogeneous cross-linking [9]. Cell cross-
linking utilizing arginine-glycine-aspartate (RGD) coupled alginate
improves attachment of adherent mammalian cell types [10],
whereas thermal gelation with thermo-responsible materials allows
cross-linking at body temperature [11]. In summary, by varying
the type and density of cross-linking, the physical and biological
properties of the bead can be controlled and matched with the
required application.
To date, three major methods are suitable for encapsulation of
living cells in alginate beads: 1) electro-spraying (ES), utilizing a
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voltage in order to detach alginate beads from the nozzle, 2) air-
flow (AF), allowing bead production using air motion under
pressure, and 3) ink-jet fabrication, a method based on piezoelec-
tric effects [12,13]. However, encapsulation methods require
further optimization in order to reduce bead size while avoiding
ruptured structures. Smaller alginate beads are preferable in cell
culture and transplantation due to increased surface-to-volume
ratio and enhanced heat and mass transfer to encapsulated cells.
Here, the application of poly-cationic coatings, such as poly-L-
lysine, has been shown to stabilize the structure of alginate beads
and control molecular weight cut-off [14], but bead biocompat-
ibility was significantly lower when compared to uncoated and
unmodified calcium and barium beads [15,16].
The terminology ‘‘mesenchymal stem cells’’ is misleading
because the mesenchyme is embryonic connective tissue from
mesodermal origin, differentiating in hematopoietic and connec-
tive tissue, which this cell type cannot. Therefore, ‘‘multipotent
stromal cells’’ (MSC) is a far more accurate term for this
interesting cell population which will be tested prior to clinical
application in the common marmoset monkey (Callithrix jacchus)
as a relevant preclinical non-human primate model. For future
application in regenerative medicine, the introduction of such a
model is more important than widely used rodent models due to
high phylogenetic similarity of a marmoset to a human and
derivation of embryonic (ESC), induced pluripotent (iPS) and
adult stem cells [17–20]. In our experiments, MSCs were derived
from the placental amnion membrane of the animals, offering a
non-invasive strategy for retrieval and theoretical availability for
each (future) patient. This is due to the fact that the amnion
membrane is generated from the embryonal epiblast, whereas the
chorion is originated from the trophoblast and the decidua from
maternal origin [21]. Immediate availability of these cells can be
assured by their long-term storage at low temperatures with
appropriate cryopreservation procedures. This is currently the
only possible technique for the long term storage of rare cell types.
The preservation of stem cells with high viability, proliferation and
yet preserving their differentiation potential called ‘‘stemness’’ still
poses challenges. One strategy to improve viability and prolifer-
ation after cryopreservation deals with the encapsulation of cells in
small-sized alginate beads before freezing. The gel-like structure,
mild environment inside alginate beads and improved heat and
mass transfer due to increased surface-to-volume ratio may protect
encapsulated cells from cryo-injury and resist the reorganization of
ice crystals during thawing.
Therefore, in this work, we applied high voltage ES to
encapsulate MSCs in small alginate beads with defined diameter.
We investigated the efficiency of the ES method to encapsulate
high cell numbers and the effects of cell concentration and cell-
mixing procedure on bead diameter. Furthermore, we evaluated
the effect of high voltage encapsulation procedure and cryopres-
ervation on viability, proliferation and differentiation of MSCs
after encapsulation, using the AF method as a comparative
approach.
Materials and Methods
All chemicals used in the study were purchased from Sigma,
unless indicated otherwise.
Alginate: source and sterilization
Medium viscosity alginate sodium salt from brown algae
(molecular weight 80000–120000 g/mol, viscosity 2000 cP (2%,
25uC)) was dissolved in 10 mM 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES, Carl Roth GmbH, Karlsruhe,
Germany) buffered saline (pH 7.4) at a concentration of 1.6% (w/
v) with gentle shaking overnight. Aliquots of alginate solution were
kept at 4uC until use. Raw alginate solution was sterilized using
0.8-0.45-0.2 mm filters. Membrane filtration of alginate solution
was used to sterilize the product, as this the only type of
sterilization that does not cause significant changes in molecular
weight and viscosity of alginate [22]. Sterile alginate solution was
transferred to 10 ml sterile syringes and kept at 4uC. Aliquots of
alginate solution were left to warm up at room temperature (RT)
one day prior to the experiments.
Encapsulation methods
We have previously designed the high voltage ES encapsulation
method and optimized the process parameters. It applies a high
voltage to overcome the surface tension of the alginate solution
(Figure 1B). Briefly, the alginate solution is held in a syringe and
passed through an adaptor under controlled flow rate to the nozzle
(blunt needle, outer/inner diameters 0.4/0.2 mm, length 25 mm,
BBraun, Melsungen, Germany). Alginate gel is detached from the
tip of the nozzle by applying a high voltage between the needle
Figure 1. Schematic presentation of alginate high voltage encapsulation. (A) Application of encapsulation of cells in alginate using high
voltage (B) in cell-based therapy for immunoisolation, controllable drug release through semi-permeable membrane (SPM) and long-term storage of
cells. Scale bar is 100 mm.
doi:10.1371/journal.pone.0107911.g001
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and the grounded electrode with following cross-linking in the
bath containing stirred solution with Ca2+ ions. Calcium ions
replace sodium ions in alginate due to their higher affinity to the
alginate, forming a gel-like structure. We compared our approach
to the commonly used AF method that does not apply a high
voltage to generate alginate beads. The detailed description of the
AF encapsulation method has been published previously [12]. In
brief, a high velocity air flow overcomes the surface tension of the
alginate solution resulting in bead detachment. The AF method
has previously been optimized for the production of alginate beads
with a narrow size distribution compared to the beads obtained
using ES approach (bead diameter 300–400 mm) [23].
The size of generated alginate beads was determined to
investigate the encapsulation efficiency. Briefly, the alginate beads
(with or without encapsulated cells) were cross-linked after
encapsulation for 30 min (unless stated otherwise). After cross-
linking, the diameter of alginate beads generated by the ES or AF
method was measured using an Axiovert 200M microscope (Carl
Zeiss, Germany). Pictures were taken in bright-field at 5X
magnification and analyzed using AxioVision software (Rel. 4.7)
(8–10 images, 10–15 beads per image). The average bead diameter
of one hundred beads was determined.
Cell derivation, characterization, culture and
encapsulation
Ethics statement. No animal experiments were performed
in this study. Donation of the placenta material after natural
birth’s was carried out from the Center for Reproductive Medicine
and Andrology Muenster (CeRA) by institutional animal care
takers and approved by the Institutional Animal Care. The ethical
husbandry of Callithrix jacchus in this institute was in accordance
with the guidelines of the Ministry for Environment and Nature
Protection, Agriculture and Consumer Protection (LANUV),
North-Rhine Westphalia, Germany.
Cell derivation and isolation. Placental samples were
collected after natural birth from healthy marmosets in the CeRA.
Placentas were washed with phosphate buffered saline (PBS,
Biochrom AG, Germany) with 1% Ciprobay (Fresenius Kabi, Bad
Homburg, Germany). Then the amnion membrane of each part of
placenta was removed and dissected into smaller pieces. The
amnion membrane pieces were incubated with 0.25% trypsin for
1 h at 37uC, filtered through 100 mm cell strainers and centrifuged
at 1,200 rpm for 5 min. The cell pellet was re-suspended in MSC
growth medium and plated into 10 cm cell dishes. All cell samples
were tested for mycoplasma contamination.
Cell culture and encapsulation. MSCs derived from the
common marmoset monkey Callithrix jacchus were cultured
under sterile conditions in Dulbecco’s modified Eagle’s medium
(DMEM, Biochrom AG, Germany) containing 15% (v/v) fetal
bovine serum (FBS, Biochrom AG, Germany), 1% penicillin/
streptomycin, 1% ascorbic acid in 10 cm tissue culture dishes
(TPP, Biochrom AG, Germany) in a humidified incubator at 37uC
and 5% CO2. The cells were harvested using 0.05%/0.02% (w/v)
trypsin/EDTA solution followed by centrifugation at 1,200 rpm
for 5 min. Membrane integrity of MSCs was assessed by trypan
blue staining using Vi-CELL XR cell viability analyzer (Beckman
Coulter GmbH, Krefeld, Germany). After counting, MSCs were
centrifuged and re-suspended in 10 mM HEPES buffered saline
(pH 7.4) to adjust the desired cell concentration before encapsu-
lation in alginate. The encapsulation was performed by the AF
and ES method; here, the cells were gently mixed with 1.6%
alginate in 10 ml syringe and pumped at 10 ml/h flow rate into
100 mM CaCl2 cross-linking solution (in 10 mM HEPES buffered
saline). The obtained alginate beads containing MSCs were
washed twice with washing solution (WS), containing 10 mM
HEPES, 1.5 mM CaCl2 buffered saline (pH 7.4), and either
immediately used for experimental purposes after encapsulation
(‘‘Immediate’’) or after a day of culture in a humidified incubator
at 37uC and 5% CO2 (‘‘Incubated’’). The presence of calcium ions
in WS prevented alginate beads from swelling [24]. The following
process parameters were kept constant during encapsulation using
both the AF and ES method: spraying distance 10 cm, alginate
flow rate 10 ml/h, concentration of CaCl2 solution 100 mM,
applied voltage 20 kV, air flow 150 l/h, unless stated otherwise.
Flow cytometry marker analysis. After trypsinization and
fixation in 4% paraformaldehyde (PFA, Merck, Germany), cells
were aliquoted in equal numbers for flow cytometry (FACS
Calibur, Becton Dickinson) and stained with primary and
secondary antibodies at RT for 1 h, respectively (Table S1). Cells
incubated with only secondary antibody were used as negative
controls.
Immunohistochemical staining. For immunohistochemi-
cal staining Dako LSAB+System-HRP kit was used (Dako North
America, California, USA). For the examination for mesenchymal
markers, 26104 cells/well of each sample were seeded on a glass
slide (20 mm) in a 12-well plate (Greiner Bio-One GmbH,
Frickenhausen, Germany) and then fixed with 4% PFA. After
washing steps with PBS, six drops of 3% hydrogen peroxide were
added to each well for 5 min to block endogenous peroxidase
activities. The cells were incubated with appropriate antibody over
night at 4uC (Table S1). Then the link solution was applied to the
glass slides for 30 min followed by streptavidin peroxidase for
30 min. The substrate solution was added to each well and
incubated for 7–15 min until the antibody horseradish peroxidase
conjugate (AB-HRP) catalyzed the 3,39-diaminobenzidine (DAB)
substrate into the desired brown to black reporter color for a
positive signal. Afterwards, cells were washed twice with 1 ml
distilled water (dH2O) and treated with 300 ml haematoxylin for
3–5 min providing counterstaining of the nuclei. The glass slides
were additionally rinsed with dH2O, transferred upside down onto
an object plate in one drop of Mowiol 4–88 (Carl Roth GmbH,
Karlsruhe, Germany) and dried over night in the dark. Images
were taken using a Keyence Biozero microscope (Keyence
Germany GmbH, Neu-Isenburg, Germany).
Total RNA Isolation and Reverse Transcription
Polymerase Chain Reaction (RT-PCR). RNA was extracted
using the peqGOLD Total RNA Kit (Peqlab GmbH, Erlangen,
Germany) according to the manufacturer’s instructions. Briefly,
the cell pellet was lysed in 400 ml RNA Lysis Buffer, transferred to
a provided DNA removing column and centrifuged at 12,000 g for
1 min. Next, 400 ml 70% ethanol were added to the flow through,
the lysate was loaded onto a provided Perfect Bind RNA Column
and centrifuged at 10,000 g for 1 min. After three washing steps
(1x 500 ml RNA Wash Buffer I and 26600 ml RNA Wash Buffer
II), the column was dried by centrifugation at 10,000 g for 2 min
and the RNA eluted from the column by applying 50 ml sterile
RNAse-free dH2O. Concentration of the obtained RNA was
measured by a Nanodrop photometer (Spectrophotometer
ND1000, Peqlab GmbH, Erlangen, Germany). Extracted RNA
was transcribed into complementary DNA (cDNA) using the High
Capacity cDNA Reverse Transcription Kit (Life technologies,
Carlsbad, USA). By adding Oligo-17-dT primers (TIB Molbiol,
Berlin, Germany) only the messenger RNA (mRNA) with intact
poly-A tail was transcribed. For the analysis of the mesenchymal
markers and immunorelevant molecules, a RT-PCR reaction of
30 ml per sample was set up with standard conditions (24 ml
dH2O, 3 ml 1X PCR buffer (NEB, Frankfurt, Germany), 0.5 Units
Taq Polymerase (NEB, Frankfurt, Germany), 100 mM nucleoside
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triphosphates containing deoxyribose (dNTPs, Fermentas, St.
Leon-Rot, Germany), 20 pmol/ml of each primer and 1 mg
cDNA). The RT-PCR reaction was performed in a Thermal
cycler C1000 (Bio-Rad Laboratories GmbH, Munich, Germany).
The cycling conditions were as follows: 1x initial denaturation step
at 95uC for 180 s, followed by 35x denaturation at 95uC for 45 s,
annealing at 58uC for 45 s, extension at 72uC for 90 s and a final
extension step at 72uC for 600 s. In all amplifications, ribosomal
protein S29 (RPS29) was utilized as a housekeeper gene; exact
oligonucleotide sequences, corresponding fragment sizes and
annealing temperatures are enlisted in Table S1.
Optimization of cell number
Cell concentration (16106, 56106, 106106 cells/ml), alginate-
cell mixing procedure and applied voltage (10, 15, 20, 25, 30 kV)
was also optimized, since the incorporation of living cells may also
change the viscosity and surface tension of final alginate-cell
solution resulting in increased bead size, thus affecting the heat
and mass transfer to the encapsulated cells. Concentration of
alginate (1.6% in 10 mM HEPES buffered saline, w/v), cross-
linking solution (100 mM in 10 mM HEPES buffered saline),
spraying distance (10 cm), and alginate flow rate (10 ml/h) were
kept constant. The diameter of alginate beads was measured as
described above.
Shrinking rate and encapsulation efficiency
Shrinking rate (SR) of alginate in presence of gelling agents
(Ca++) was analyzed by comparing the initial volume of alginate
droplets detached from the nozzle via gravity (manual dropping,
MD), AF and high voltage. The volume of alginate beads was
calculated by the diameter after cross-linking for 40 min. The
volume at t = 0 revealed the initial volume of alginate droplet. The
MD, AF and ES method was utilized to generate beads with
different surface-to-volume ratios (S/V) as a result of initial bead
diameter. The initial volume (also respective S/V ratio) was
calculated by dropping the alginate solution on the collector and
calculating the amount of generated droplets vs. dropping time.
This preliminary experiment was performed ten times providing
the resulted S/V ratios (assuming the alginate drop having a form
of a sphere) of 2.47, 9.15, 8.28 and 11.47 mm21 for 1.5%-MD,
1.2%-AF, 1.5%-AF and 1.5%-ES of experimental settings,
respectively. The volume of alginate beads during gelling was
calculated from measuring their diameter at defined time points
during gelling: from 0 to 5 min with a step of 1 min, from 5 to
40 min with a step of 5 min. In general, SR can be presented as
follows:
SRt~
V0
Vt
ð1Þ
whereas V0 – initial volume of alginate drop, Vt – volume of
alginate bead at time t of cross-linking. The value of SR calculated
for 1.5%-ES and 10 min of gelling was used to analyze the
efficiency of encapsulation of MSCs in alginate at a concentration
of 16106, 56106 and 106106 cells/ml. In this particular case
(alginate concentration 1.5%, cross-linking time 10 min), assuming
no release of cells from the alginate bead during spraying and
gelling, the final number of cells encapsulated in alginate bead was
evaluated as follows:
Cell Number~C0|SRt|Vt ð2Þ
whereas C0 – initial cell concentration (cells/ml), SRt – shrinking
rate of alginate after time t of gelling, Vt – volume of alginate bead
after time t of gelling (ml).
Cell viability
MSCs were encapsulated into 1.6% alginate using AF and ES
under high voltage (15, 20, 25, 30 kV) followed by washing steps.
After washing, alginate beads were transferred to 6-well culture
dishes (TPP, Biochrom AG, Germany) and cultured for 10 days in
a humidified incubator at 37uC, 5% CO2 with daily cell culture
medium change. At defined time points (day 0, 1, 3, 5, 7 and 10),
approximately 20 beads were taken, washed twice with WS and
stained for live-dead viability based on previously published
protocol with some modifications [25]. CalceinAM indicated
viable cells upon their enzymatic activity by green fluorescence
(excitation/emission: 494/517 nm), whereas Ethidium Homody-
mer (CalceinAM/EthD, Sigma, USA) indicated dead cells with
ruptured cell membranes in red (excitation/emission: 528/
617 nm) by intercalating to the nuclear DNA of the cell nuclei.
Equal volumes of beads containing cells in HEPES and working
solution of the live-dead staining were mixed to get the final
concentrations of 2 mM and 4 mM of CalceinAM and Ethidium
Homodymer, respectively, and incubated for 10 min in the dark at
RT. After staining beads were washed twice with WS and
immediately imaged using an Axiovert 200M fluorescence
microscope at 56magnification to detect viable and dead MSCs.
Separate images of live and dead cells were analyzed using
AxioVision software (Rel. 4.7).
Cell recovery
To evaluate the proliferation and differentiation capacity of
differently encapsulated MSCs, the cells were allowed to release
from the alginate beads by 55 mM sodium citrate in 10 mM
HEPES buffered saline (pH 7.4) with gentle shaking for 5 min,
thus replacing calcium ions by sodium ions. This resulted in
formation of diluted sodium alginate and the release of MSCs
from the beads. The cells were further collected by centrifugation
at 1,200 rpm for 5 min and the proliferation and differentiation
potential after encapsulation, incubation and cryopreservation
evaluated. Because the recovery of cells might not be finished in
only 24 h, we cultured the MSCs in 6-well culture flasks at a
concentration of 16105 cells/well in a humidified incubator at
37uC and 5% CO2 for 5 days. After this period of time, we
assessed the cell number, membrane integrity and further seeded
cells for proliferation assay.
Cell proliferation
The MSCs were seeded in 96-well culture flasks (TPP,
Biochrom AG, Germany) at a concentration of 16104 cells/well
for the CellTiter 96 Non-radioactive Cell Proliferation Assay
(G4000, Promega, USA) following manufacturer’s protocol.
Briefly, after 24 h in culture flasks in a humidified incubator
(37uC/5% CO2), 15 ml dye solution of the proliferation assay was
added to each well and incubated for 4 h to let living cells convert
the tetrazolium component of the dye solution into formazan
crystals. After the addition of 100 ml stop solution, the well was
incubated for 1 h in the dark to solubilize the formed formazan
crystals and the absorbance was measured at 570 nm wavelength
using 96-well micro-plate reader (Multiscan Ex, Thermo Scientif-
ic, China). Absorbance values were normalized with controls of
cultured cells without encapsulation and cryopreservation.
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Characterization of differentiation potential
MSCs were encapsulated using the high voltage (20 kV) and AF
method, released from the beads, tested for viability as described
above and seeded at a density of 56104 cells/well in 6-well culture
dishes. The differentiation of MSCs towards adipogenic and
osteogenic lineages was performed following the protocol pub-
lished by our group [26].
Adipogenic. Adipogenic differentiation of MSCs was induced
by culture of the cells for 5 days in medium containing 1 mM
dexamethasone, 0.2 mM indomethacin, 0.5 mM 3-Isobutyl-1-
methylxanthin and 10 mg/ml insulin in DMEM supplemented
with 10% FBS. Detection of formed lipid vacuoles was assessed
using Oil Red O stain as described earlier [26]. Briefly, the cells
were washed with PBS, fixed in 4% PFA for 20 min and rinsed
twice with tap water followed by one final wash with 50% ethanol
(ROTH, Germany). Formed lipid vacuoles were detected by
incubation for 10 min in Oil Red O in acetone/50% ethanol
(Merck, Germany) and a final rinse with tap water. All
differentiation procedures were repeated four times, compared
with undifferentiated control cells (n = 4) and visualized with an
Axiovert 200M microscope in bright field.
Osteogenic. The cells were cultured in osteogenic differen-
tiation medium supplemented with 0.1 mM dexamethasone,
10 mM glycerophosphate, 0.05 mM L-ascorbic acid-2-phosphate
and 1% ITS (BD Biosciences, Germany) in DMEM with 15%
FBS. To detect mineralization of differentiated osteoblasts, Von
Kossa staining was performed as described earlier [26]. Briefly,
MSCs with the mineral deposit were washed twice in PBS and
fixed with 10% PFA, washed once with PBS and twice with dH2O
followed by addition of 1% silver nitrate (Ridel de Haen GmbH,
Germany). In the following, the dish was exposed to sunlight for
30 min, washed with bi-distilled water (bi-dH2O), stained with 5%
sodium thiosulfate for 5 min and again rinsed with bi-dH2O.
All differentiation procedures were repeated four times,
compared with undifferentiated control cells (n = 4) and visualized
with an Axiovert 200M microscope in bright field.
Cryopreservation
The MSCs were encapsulated and cryopreserved at a concen-
tration of 0.56106 cells/sample either immediately after encap-
sulation (‘‘Immediate’’) or after cultivation in culture medium in a
humidified incubator at 37uC, 5% CO2 for 24 h (‘‘Incubated’’).
Cells encapsulated in alginate under high voltage (15, 20, 25 kV)
and using the AF method were washed twice with WS and
exposed to 2X freezing medium at 4uC drop-wise (0.5 ml/min),
containing 20% (v/v) dimethyl sulfoxide (DMSO, Carl Roth
GmbH, Germany) and 20% FBS to obtain the final concentration
of 10% DMSO and 17.5% FBS. Samples were equilibrated at 4uC
for 15 min in 1.5 ml cryo-vials (TPP, Biochrom AG, Germany)
and cooled down at 1 K/min (slow cooling protocol) down to 2
80uC with Mr. Frosty Freezing Container (Thermo Fisher
Scientific, Schwerte, Germany), without active control over the
temperature of extracellular ice formation (spontaneous ice
formation). Frozen samples were transferred to 2150uC and kept
for 7 days before thawing at 37uC in a water bath for 2 min. The
thawing rate was as follows: from 2150uC to 225uC with 243 K/
min, from 225uC to 4uC with 18 K/min (Figure S1). In order to
reduce the negative effect of osmotic stress which takes place
during fast dilution procedure, the thawed samples were further
diluted by drop-wise addition of fresh culture medium at 4uC. The
cells were released from the beads as described above, checked for
membrane integrity by trypan blue staining and seeded for
proliferation assay either immediately after thawing or after being
recovered for 5 days in culture. As control, non-encapsulated
MSCs in suspension were also cryopreserved under the same
conditions.
Data analysis and statistics
The data are shown as a mean6SD. Here, ‘‘n’’ represents the
number of independent experiments with ‘‘N’’ samples each.
Significance level was analyzed using one-way ANOVA with a
mean comparison using Tukey method with Microsoft Excel 2007
software. The level of p,0.05 was assumed as significant.
Results
Characterization of the MSCs
Primary culture obtained from amnion membrane displayed
high proliferation capacities until passage 26 (data not shown).
Flow cytometry analysis demonstrated 87.5664.92% of the cells
were positive for MSC maker CD105 (ENG) and 85.0064.28% –
for CD73 (NT5E, Figure 2A). Immunohistochemistry showed
positive brown to black reporter color for CD90 (THY-1), CD105
(ENG), Brachyury (Bra) and Snail-1 (Figure 2B–E). MSC charac-
teristic genes like THY-1, ITGA6, GFRa1, CD73, CD105,
ALCAM and CD44 were detected also in RT-PCR, whereas
hematopoietic marker CD34 was absent (Figure 2F).
Optimization of cell encapsulation
Effect of cell encapsulation on bead diameter. For
transplantation and pre-clinical studies, the size of alginate beads
is one of the main factors, limiting diffusion of nutrients to
encapsulated cells and vice versa the release of cell produced
substances. The initial concentration of cells and alginate-cell
mixing procedure may affect the resulting bead diameter and the
performance of alginate beads after transplantation. In order to
investigate these parameters, we encapsulated MSCs into 1.6%
alginate with three different cell concentrations and under the
range of voltage from 10 to 30 kV (Figure 3A). At the region
below 10 kV, the strength of electric field was much lower than the
surface tension, resulting in dropping mode and a bead size
inapplicable for cell culture (.1 mm). At non stable region (10–
15 kV), the slight increase in applied voltage had a pronounced
effect on bead diameter, allowing to generate beads sized from
1,000 mm to less then 300 mm, respectively (dripping mode).
Further increase in voltage did not significantly alter bead
diameter (jetting mode). Such behavior has previously been
reported, however, without encapsulated cells [27,28]. In addition,
concentration of 1.5% alginate was simulated by diluting
appropriate volumes of 1.6% alginate with HEPES solution.
Interestingly, an increase of cell concentration from 16106 to
106106 cells/ml of initial alginate did not have noticeable
influence on bead diameter (Figure 3A), indicating that large
number of cells can be encapsulated without altering the size of
alginate beads.
Encapsulation efficiency. It is especially important in
therapies with a cell-based drug delivery system to precisely
calculate the amount of encapsulated cells in alginate beads. We
investigated the efficiency of encapsulation by analyzing the
shrinking rate of alginate during cross-linking. The shrinking rate
of alginate (1.5% and 1.2%, w/v) in cross-linking solution without
encapsulated cells depending on initial surface-to-volume ratio at
defined time intervals and for a maximum of 40 min is shown in
Figure 3B. Interestingly, the alginate beads possessing higher S/V
ratio showed very fast and uncontrollable shrinking over the first
5 min of gelling, whereas those obtained by MD were shrinking
stable and slow (Figure 3B, AF-ES vs. MD). In opposite, alginate
drops generated via ES method and possessing the highest value of
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S/V ratio (11.47 mm21) showed extremely fast shrinking during
the first 5 min of cross-linking.
Calculating the number of cells to be entrapped in one bead
(Figure 3C) with equation (2), the alginate beads contained 16106,
56106 and 106106 cells/ml and showed virtually homogeneous
distribution of cells throughout the bead (Figure 3C, C1–C3). The
cell concentration barely affected the size of alginate bead for a
wide range of applied high voltage (Figure 3A). The average
diameter of alginate beads was equal to 300 mm for each cell
concentration. In exact numbers, we could show that it is possible
to entrap 48 to 483 cells in an alginate bead for 16106 and
106106 cells/ml, respectively.
Viability after encapsulation
In order to evaluate if the high voltage of the ES method affects
the viability of cells especially by membrane damages, we utilized
the trypan blue assay as a solid marker for membrane integrity of
cells; however, the release of cells from the beads by immersing in
sodium citrate and additional centrifugation may also lead to cell
death by apoptosis. To reveal this effect, we stained encapsulated
MSCs additionally at day 0, 1, 5, 10 with CalceinAM/EthD. We
observed no noticeable effect of high voltage on viability of cells
both post-encapsulation and incubation of MSCs inside alginate
beads for 10 days as compared to AF (Figure 4, AF-30 kV).
However, we noticed the negative effect of incubation time on the
viability of encapsulated cells as compared to shorter incubation
periods (Figure 4, day 10 vs. day 1). Despite this, most of cells were
Figure 2. Characterization of amnion derived multipotent stromal cells. (A) FACS analysis with characteristic markers CD105 and 73
(mean6SD, n = 4). (B–E) Immunohistochemistry stainings with MSC markers CD105, CD90, Bra and Snail1. (F) RT-PCR analysis displays presence of
characteristic MSC markers CD90, ITGA6, GFRa1, CD73, CD105, ALCAMm CD44, whereas CD34 as marker for hematopoietic progenitors is absent
(housekeeper RPS29). Scale bars are 50 mm.
doi:10.1371/journal.pone.0107911.g002
Figure 3. Optimization of cell concentration and cell number. (A) Effect of applied voltage, initial cell concentration and alginate-cell mixing
procedure on diameter of alginate beads (mean6SD). (B) Shrinking of alginate in presence of 100 mM CaCl2 depending on gelling time for different
initial surface-to-volume ratio (S/V) and (C) calculation of encapsulation efficiency of MSCs in alginate beads. Shrinking rate was analyzed based on
decrease in volume during gelling caused by water release for: MD – manual dropping of alginate solution, AF – using air-flow method and ES – using
electro-spraying; dotted lines show the tendency of shrinking outside the studied cross-linking time. (C) Effect of initial cell concentration on number
of encapsulated cells and respective photographs of alginate encapsulated MSCs at initial concentration of 16106 (C1), 56106 (C2) and 106106 (C3)
cells/ml. The next process parameters were kept constant: both for AF and ES – spraying distance 10 cm, concentration of gelling solution 100 mM
CaCl2, alginate flow rate 10 ml/h, and alginate concentration from 1.2% to 1.6% (w/v); for AF – air flow 150 l/h; for ES – applied voltage 20 kV. The
data are presented as a mean6SD (n = 3, N= 10). Scale bars are 200 mm.
doi:10.1371/journal.pone.0107911.g003
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still viable at day 10. It should be noted that the effect of high-
voltage on viability of encapsulated cells cannot be properly
evaluated, since the beads obtained under 20, 25 and 30 kV had a
smaller diameter as compared to AF and 15 kV. Thus, fewer
viable cells were detected.
Cell proliferation
Proliferation of encapsulated MSCs. We evaluated the
effect of high voltage and incubation time of bead-enclosed cells on
proliferation after encapsulation (Figure 5A1) and after recovery
(Figure 5A2). Here, the encapsulation procedure and applied high
voltage does not significantly affect the viability of encapsulated
MSCs, as indicated by similar proliferation efficiency and
metabolic activity as controls. Moreover, MSCs derived from
alginate beads immediately after encapsulation recovered with the
same rate as controls, but proliferation decreased significantly after
24 h of incubation. The recovery of MSCs post-encapsulation was
dependent on pre-incubation time; such non-incubated cells
(seeded for proliferation assay immediately after encapsulation)
recovered at the same rate as a native control (Figure 5A2,
‘‘Immediate’’). However, MSCs incubated in beads for 24 h
showed a significantly lower recovery rate (Figure 5A2, ‘‘Incubat-
ed’’).
Proliferation of encapsulated MSCs after
cryopreservation. For long-term storage it is necessary to
provide alginate encapsulated cells with high viability and
proliferation after cryopreservation. The proliferation of frozen
cells inside alginate structures incubated for 24 h (Figure 5B1,
‘‘Incubated’’) was significantly lower in comparison with native
control (Figure 5B1, ‘‘CN’’). Interestingly, MSCs frozen inside
alginate beads immediately after encapsulation revealed signifi-
cantly higher proliferation rate as compared to the cells incubated
for 24 h inside beads; whereas the proliferation rate was slightly
lower for encapsulated and immediately frozen cells as compared
to frozen control cells (Figure 5B1, ‘‘CF’’). The recovery of MSCs
post-cryopreservation was also affected by incubation time
(Figure 5B2). In addition, MSCs frozen inside alginate beads
possessed higher recovery rate as compared to frozen control cells
and the same rate as fresh control cells (Figure 5B2, ‘‘CF’’–‘‘CN’’).
Application of high voltage to generate cell-containing alginate
beads did not alter the metabolic activity of cells after thawing, as
for ‘‘Immediate’’ and ‘‘Incubated’’ groups we did not observe the
negative effect of high voltage on MSCs as compared to AF
encapsulated ones (Figure 5B1–B2, 15–25 kV vs. AF).
In summary, the cryopreservation procedures reduced the
number of cells with intact membrane. We showed that 6265% of
the cells were viable after thawing of cryopreserved MSCs directly
after encapsulation, as compared to initially encapsulated ones
(n = 3, N = 5). On the other hand, only 3067% of cells were alive
after applying pre-freeze incubation of MSCs inside alginate beads
in culture for 24 h. We further detected the number of not
encapsulated frozen MSCs of 7663% after thawing, as compared
Figure 4. Viability of encapsulated MSCs vs. applied voltage and incubation time. Live-dead staining with CalceinAM (2 mM) and Ethidium
Homodymer (4 mM). Note: beads obtained under 15 kV and using air flow (AF) had slightly bigger diameter as compared to the others. Viable cells
stained in green, cells with massive membrane damages – in red. No visible difference in viability of encapsulated cells depending on applied voltage
can be observed. The next process parameters were kept constant: both for AF and electro-spraying – spraying distance 10 cm, concentration of
gelling solution 100 mM CaCl2, alginate flow rate 10 ml/h, and alginate concentration 1.6% (w/v); for AF – air flow 150 l/h. Scale bar is 100 mm.
doi:10.1371/journal.pone.0107911.g004
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to initially frozen cells. The number of cells recovered after
thawing increased in 4.9 and 2.9 times after 5 days for
immediately frozen and incubated for 24 h before cryopreserva-
tion (as compared to the number of cells seeded for recovery
assay), respectively. According to our data, the number of not
encapsulated frozen MSCs and fresh control increased in 4.6 and
4.8 times, respectively.
Proliferation of MSCs cultured inside beads for 7
days. During evaluation of the effect of high voltage on
proliferation of cells as compared to the AF method for a period
of 7 days, we found that the viability and proliferation of
encapsulated cells was decreasing during the incubation which
resulted in significant decrease at day 7 independent from
encapsulation method (Figure 6, day 7 vs. day 0). The cells
seeded for proliferation immediately after encapsulation at 20 and
25 kV of high voltage showed slightly lower proliferation as
compared to AF encapsulated MSCs. However, further incubation
did not reveal significantly different effect of high voltage on the
viability and proliferation of cells post-incubation as compared to
AF method. In summary, the encapsulated cells proliferated slower
as compared to non-encapsulated control cells.
Differentiation capacity
We studied the effect of high voltage on the capacity of
encapsulated MSCs to differentiate into adipogenic and osteogenic
lineages. MSCs were able to form adipocytes (Oil Red O staining)
and osteocytes (Von Kossa staining) post-encapsulation (Figure 7).
We detected no visible difference in the plasticity for MSCs
encapsulated in alginate using high voltage (20 kV) and AF
method to form lipid vacuoles (Figure 7, Oil Red O/Positive) and
mineralize calcium phosphate (Figure 7, Von Kossa/Positive).
Non-encapsulated MSCs also showed the capacity to differentiate
into adipocytes and osteocytes (Figure 7, Fresh), whereas untreat-
ed control cells without differentiation media did not display
vacuoles or mineralization.
Discussion
High voltage has been widely used in bioengineering and
regenerative medicine. Such applications include a) electrophore-
sis to extract DNA and proteins and b) electroporation to
permeabilize the cell membrane to deliver genes and liposome
into the cells and tissues to treat rare diseases and store rare cell
types for long term [29–31]. In these approaches, the strength of
electric field ranges from 1–10 V/cm of constant voltage for gel
Figure 5. Effect of applied encapsulation methods and incubation on proliferation of MSCs post-encapsulation and
cryopreservation. Proliferation of MSCs: (A1) after encapsulation in alginate; (A2) after recovery post-encapsulation; (B1) cryopreserved in
alginate; (B2) after recovery post-thawing. ‘‘Recovery’’ – incubation of cells in culture (37uC, 5% CO2 in a humidified incubator) for 5 days after
encapsulation and/or cryopreservation; ‘‘Immediate’’ – immediately after encapsulation; ‘‘Incubated’’ – after 24 h of incubation inside alginate beads
in culture; AF – air flow; CF – frozen not encapsulated cells; CN – not encapsulated and not frozen MSCs. The next process parameters were kept
constant during encapsulation: both for AF and electro-spraying – spraying distance 10 cm, concentration of gelling solution 100 mM CaCl2, alginate
flow rate 10 ml/h, and alginate concentration 1.6% (w/v); for AF – air flow 150 l/h. In B1–B2 freezing parameters included cooling rate 1 K/min down
to280uC and freezing medium with 10% DMSO and 10% FBS. The data are shown as a mean6SD (n = 3, N= 5). One-way ANOVA: NS – not significant
(p = 0.05); *, **, *** - significantly different with p,0.05, p,0.01, p,0.001, respectively.
doi:10.1371/journal.pone.0107911.g005
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electrophoresis up to 100 kV/cm of pulse high voltage (the pulse
duration can vary depending on application) for conventional
electroporation (the pulse duration is in microsecond range) [32]
and supra-electroporation (nanosecond pulsed electric field)
causing high density nanopore formation in all cell membranes
[33]. In our experiments we generated small-sized alginate beads
with encapsulated MSCs applying the strength of electric field
ranging from 1 kV/cm to 3 kV/cm. Comparing the high voltage
method with the commonly used AF, we could show that the
range of applied high voltage from 15 to 25 kV did not alter the
viability, proliferation and differentiation capacity of MSCs after
encapsulation in alginate. Although high voltage showed a
significant effect on the proliferation rate of MSCs immediately
after encapsulation depending on the method utilized (Figure 5A1,
25 kV vs. ‘‘CN’’), there was no significant difference observed for
7 days in culture (Figure 6, ‘‘NS’’).
The findings mentioned above correlate with our recent data on
cell counts in studies after encapsulation and cryopreservation
[34]. MSCs encapsulated in alginate beads may require longer
periods of time to recover post-encapsulation; maybe due to
limited diffusion of serum molecules through the negatively
charged alginate porous structure - a problem that might get
solved by applying higher FBS concentrations. It has previously
been shown that an application of 3 kV/cm did not alter the
viability of cells [35,36]. In addition, the high voltage encapsula-
tion of living cells supports cells with a mild environment during
encapsulation that has also been suggested, but for impulse voltage
[37].
Encapsulation of cells in alginate has been known since late
1960s and has been widely applied in mice, rats and rabbits as
preclinical models [8]. However, the genotype and phenotype of
these animals is very different compared to the human, especially
in the field of stem cells research with an application of very
experimental cell types like ESCs and iPS cells with very early
features of cellular maturity. In the human, multipotent stromal
cells are to date the only cell type already utilized in clinical trials
[38]. This made them ideal assets in our experiments for
extraction, cultivation, encapsulation and differentiation. True
multipotent stromal cells with high ‘‘stemness’’ from the placental
amnion of the common marmoset monkey can be natively
obtained for personalized therapies and possible option of
transplantation in our non-human primate model without ethical
concerns or clinical safety problems.
The proliferation of encapsulated MSCs reduced after 7 days in
culture as compared to not encapsulated control cells. It may be
related to the restriction of space as well as the effects of hampered
diffusion of nutrients and FBS to encapsulated cells, especially to
centrally positioned ones, as it has been reported previously [39].
In addition, the negative effect of washing steps and liquefying
procedures (release of cells from alginate beads) can not be
excluded. One of the possible solutions could be an increase of
concentration of FBS, along with a decrease in bead diameter,
which could improve heat and mass transfer through the bead. A
similar solution has also been suggested, showing that alginate has
to be modified to allow attachment and proliferation of adherent
mammalian cell types [40–42]. This could support our observation
on a decrease of the viability and metabolic activity of
encapsulated cells over the incubation period. On the other hand,
the metabolic activity of encapsulated adherent mammalian cell
types may be improved by modifying the initial alginate with RGD
peptides [10]. These modifications have been shown to improve
survival of cells after cryopreservation as compared to cells
encapsulated in unmodified alginate. In this work, we showed that
non-human primate MSCs encapsulated using high voltage can be
readily stored at low temperatures for long term without altering
the metabolic activity of cells after thawing, as compared to not
encapsulated MSCs. In addition, by studying the shrinking rate of
alginate we were also able to quantify the number of cells to be
entrapped in one bead for the respective S/V ratio of
11.47 mm21.
To our knowledge, there is to date no single study with a
complete and comparative characterization of amnion derived
encapsulated and cryopreserved MSCs including optimization of
cell number, evaluation of metabolic activity of cells after
encapsulation and cryopreservation and evaluation of the effect
of encapsulation method on the differentiation potential of alginate
encapsulated MSCs.
Conclusions
The MSCs derived from a marmoset amnion proved to be true
multipotent stromal cells with ‘‘stemness’’ and plasticity. They can
be encapsulated in unmodified alginate beads at high concentra-
tion using high-voltage encapsulation with narrow size distribution
and preserving the viability and proliferation of cells after
encapsulation. In particular, optimization of process parameters
of the ES method revealed only a slight influence of cell number
on bead size. This indicates the possibility for large-scale
generation of encapsulated cells that has previously been shown
to be the critical point in translation of encapsulation technology
to clinical application requiring high cell numbers [43]. The cells
encapsulated using the high voltage method proliferated at the
same rate as non-encapsulated cells and the cells encapsulated
utilizing the traditional AF method. Incubation of MSCs in
alginate in culture showed a significant decrease in proliferation 5
days after encapsulation, but MSCs were still viable at day 10. In
addition, we showed that cryopreservation of MSCs inside alginate
beads should be performed immediately after encapsulation to
Figure 6. Effect of encapsulation method and period of
incubation of MSCs inside beads on proliferation of cells. MSCs
were encapsulated in alginate beads using air flow (AF) and high
voltage (15, 20, 25 kV) and incubated for 0, 1, 3, 5 and 7 days inside
beads in culture (37uC, 5% CO2 in a humidified incubator). Culture
medium was replaced each second day to a fresh one. The next process
parameters were kept constant: both for AF and electro-spraying –
spraying distance 10 cm, concentration of gelling solution 100 mM
CaCl2, alginate flow rate 10 ml/h, and alginate concentration 1.6% (w/v);
for AF – air flow 150 l/h. The data are shown as a mean6SD (n = 2,
N = 5). One-way ANOVA: NS – not significant (p = 0.05); *** –
significantly different (p,0.001).
doi:10.1371/journal.pone.0107911.g006
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ensure high proliferation rates of cells after thawing. Further work
should be aimed at establishing of alternative cryopreservation
protocols for freezing of encapsulated MSCs with a control over
the temperature of ice formation, which could improve the
cryopreservation outcome. This work may give a background to
further develop a preclinical therapy with high voltage alginate
encapsulated MSCs in our non-human primate model towards
human application.
Supporting Information
Figure S1 Thawing rate of alginate encapsulated MSCs.
DMSO was added to the sample at 4uC at a rate of 0.5 ml/min
(drop-wise). The thermocouple was frozen at the center of a
cryovial so that it was positioned at the point which separates
equal volumes of freezing medium containing alginate encapsu-
lated cells. The frozen sample was removed from 2150uC and
thawed immediately in a water bath at 37uC with gentle shaking
until a small ice crystal was visible. The temperature increase was
monitored each 3 seconds. Each point represents the results of
measuring the thawing rate of 3 frozen samples.
(TIF)
Table S1 Oligonucleotides and antibodies utilized for
MSCs characterization.
(DOC)
Figure 7. Differentiation capacity of encapsulated MSCs. MSCs were differentiated into adipogenic (Oil Red O) and osteogenic direction (Von
Kossa) after encapsulation using air flow (AF) and high voltage (20 kV) followed by dilution of alginate with 55 mM sodium citrate for 5 min, or as not
encapsulated MSCs. Cells expanded in regular culture medium represent the negative control (37uC, 5% CO2 in a humidified incubator) and stained
the same as positive cells of respective lineage. The next process parameters were kept constant: both for AF and electro-spraying (ES) – spraying
distance 10 cm, concentration of gelling solution 100 mM CaCl2, alginate flow rate 10 ml/h, and alginate concentration 1.6% (w/v); for AF – air flow
150 l/h; for ES – applied voltage 20 kV. Scale bar is 100 mm.
doi:10.1371/journal.pone.0107911.g007
Encapsulation of Monkey MSCs in Alginate via High Voltage
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e107911
Acknowledgments
The authors acknowledge Julia Struss for technical assistance, Holger
Zernetsch for the help with figure design and Prof. S. Schlatt for the kind
donation of placental material.
Author Contributions
Conceived and designed the experiments: OG. Performed the experiments:
OG DP OP. Analyzed the data: OG. Contributed reagents/materials/
analysis tools: NH TM BG. Contributed to the writing of the manuscript:
OG TM. Critically revised the manuscript: DP OP NH TM BG. Gave
final approval of the version to be published: TM BG.
References
1. Portero A, Orive G, Hernandez RM, Pedraz JL (2010) Cell encapsulation for
the treatment of central nervous system disorders. Rev Neurol 50: 409–419.
2. Lee MK, Bae YH (2000) Cell transplantation for endocrine disorders. Adv Drug
Deliv Rev 42: 103–120.
3. Wollert KC, Drexler H (2006) Cell-based therapy for heart failure. Curr Opin
Cardiol 21: 234–239.
4. Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, et al. (2003)
Cell encapsulation: promise and progress. Nat Med 9: 104–107.
5. Figueiredo CS, Wedekind D, Mu¨ller T, Vahlsing S, Horn PA, et al. (2013)
MHC universal cells survive in an allogeneic environment after incompatible
transplantation. Biomed Res Int, doi: 10.1155/2013/796046.
6. Li RH (1998) Materials for immunoisolated cell transplantation. Adv Drug Deliv
Rev 33: 87–109.
7. Pawar SN, Edgar KJ (2012) Alginate derivatization: A review of chemistry,
properties and applications. Biomaterials 33: 3279–3305.
8. Chang TMS (1964) Semipermeable microcapsules. Science 146: 524–526.
9. Lee KY, Rowley JA, Eiselt P, Moy EM, Bouhadir KH, et al. (2000) Controlling
mechanical and swelling properties of alginate hydrogels independently by cross-
linker type and crosslinking density. Macromolecules 33: 4291–4294.
10. Rowley JA, Madlambayan G, Mooney DJ (1999) Alginate hydrogels as synthetic
extracellular matrix materials. Biomaterials 20: 45–53.
11. Rzaev ZMO, Dincer S, Piskin E (2007) Functional copolymers of Nisopropy-
lacrylamide for bioengineering applications. Progr Polym Sci 32: 534–595.
12. Chan ES, Lim TK, Ravindra P, Mansa RF, Islam A (2012) The effect of low air-
to-liquid mass flow rate ratios on the size, size distribution and shape of calcium
alginate particles produced using the atomization method. J Food Eng 108: 297–
303.
13. Huang SB, Wu MH, Lee GB (2010) Microfluidic device utilizing pneumatic
micro-vibrators to generate alginate microbeads for microencapsulation of cells.
Sens Actuators B Chem 147: 755–764.
14. Ma X, Vacek I, Sun A (1994) Generation of alginate-poly-l-lysine-alginate (APA)
biomicrocapsules: the relationship between the membrane strength and the
reaction conditions. Artif Cells Blood Substit Immobil Biotechnol 22: 43–69.
15. Rokstad AM, Brekke OL, Steinkjer B, Ryan L, Kolla´rikova´ G, et al. (2011)
Alginate microbeads are complement compatible, in contrast to polycation
containing microcapsules, as revealed in a human whole blood model. Acta
Biomater 7: 2566–2578.
16. Zimmermann H, Zimmermann D, Reuss R, Feilen PJ, Manz B, et al. (2005)
Towards a medically approved technology for alginate-based microcapsules
allowing long-term immunoisolated transplantation. J Mater Sci Mater Med 16:
491–501.
17. Nature Publishing Group (2009) The common marmoset: biomedical super-
model Nature 459: 7246.
18. Mansfield K (2003) Marmoset models commonly used in biomedical research.
Comp Med 53: 383–392.
19. Mu¨ller T, Fleischmann G, Eildermann K, Ma¨tz-Rensing K, Horn PA, et al.
(2009) A novel embryonic stem cell line derived from the common marmoset
monkey (Callithrix jacchus) exhibiting germ cell-like characteristics. Hum
Reprod 24: 1359–1372.
20. Wiedemann A, Hemmer K, Bernemann I, Go¨hring G, Pogozhykh O, et al.
(2012) Induced pluripotent stem cells generated from adult bone marrow-
derived cells of the nonhuman primate (Callithrix jacchus) using a novel quad-
cistronic and excisable lentiviral vector. Cell Reprogram 14: 485–496.
21. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC (2005) Stem cell characteristics
of amniotic epithelial cells. Stem Cells 23: 1549–1559.
22. Vandenbossche GMR, Remon GP (1993) Influence of the sterilization process
on alginate dispersion. J Pharm Pharmacol 45: 484–486.
23. Gryshkov O, Hofmann N, Glasmacher B (2013) Electropsraying as a promising
technique for cell encapsulation in semi-permeable micro-capsules for
immunoisolation. Cryo Letters 34: 186.
24. Mørch YA, Donati I, Strand BL, Skja˚k-Braek G (2006) Effect of Ca2+, Ba2+,
and Sr2+ on alginate microbeads. Biomacromolecules 7: 1471–1480.
25. Xie J, Wang CH (2007) Electrospray in the dripping mode for cell
microencapsulation. J Colloid Interface Sci 312: 247–255.
26. Bernemann I, Mueller T, Blasczyk R, Glasmacher B, Hofmann N (2011)
Colonization of collagen scaffolds by adipocytes derived from mesenchymal stem
cells of the common marmoset monkey. Biochem Biophys Res Commun 411:
317–322.
27. Klokk TI, Melvik JE (2002) Controlling the size of alginate gel beads by use of a
highelectrostatic potential. J Microencapsul 19: 415–424.
28. Shi P, He P, Teh TKH, Morsi YS, Goh JCH (2011) Parametric analysis of shape
changes of alginate beads. Powder Technology 210: 60–66.
29. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene
transfer into mouse lyoma cells by electroporation in high electric fields.
EMBO J 1: 841–845.
30. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70.
31. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer’s Achilles’ heel.
Cancer Cell 13: 472–482.
32. Neumann E, Rosenheck K (1972) Permeability Changes Induced by Electrical
Impulses in Vesicular Membranes. J Memb Biol 10: 279–290.
33. Stewart DA, Gowrishankar TR, Weaver JC (2004) Transport lattice approach to
describing electroporation: Use of local asymptotic model. IEEE Transact
Plasma Sci 32: 1696–1708.
34. Gryshkov O, Pogozhykh D, Zernetsch H, Hofmann N, Mueller T, et al. (2014)
Process engineering of high voltage alginate encapsulation of mesenchymal stem
cells. Mater Sci Eng C Mater Biol Appl 36: 77–83.
35. Zhang W, He X (2009) Encapsulation of living cells in small (,100 mm) alginate
microcapsules by electrostatic spraying: a parametric study. J Biomech Eng,
doi:10.1115/1.3153326.
36. Im do J, Noh J, Yi NW, Park J, Kang IS (2011) Influences of electric field on
living cells in a charged water-in-oil droplet under electrophoretic actuation.
Biomicrofluidics, doi: 10.1063/1.3665222.
37. Lewinska D, Rosinski S, Werynski A (2004) Influence of process conditions
during impulsed electrostatic droplet formation on size distribution of hydrogel
beads. Artif Cells Blood Substit Immobil Biotechnol 32: 41–53.
38. Ng TK, Fortino VR, Pelaez D, Cheung HS (2014) Progress of mesenchymal
stem cell therapy for neural and retinal diseases. World J Stem Cells 26: 111–
119.
39. Huang X, Zhang X, Wang X, Wang C, Tang B (2012) Microenvironment of
alginate-based microcapsules for cell culture and tissue engineering. J Biosci
Bioeng 114: 1–8.
40. Berrier AL, Yamada KM (2007) Cell–matrix adhesion. J Cell Physiol 213: 565–
73.
41. Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, Griffith LG (2002) Co-
regulation of cell adhesion by nanoscale RGD organization and mechanical
stimulus. J Cell Sci 115: 1423–1433.
42. de Vos P, Bucˇko M, Gemeiner P, Navra´til M, Svitel J, et al. (2009) Multiscale
requirements for bioencapsulation in medicine and biotechnology. Biomaterials
30: 2559–2570.
43. Serra M, Brito C, Correia C, Alves PM (2012) Process engineering of human
pluripotent stem cells for clinical application. Trends Biotechnol 30: 351–359.
Encapsulation of Monkey MSCs in Alginate via High Voltage
PLOS ONE | www.plosone.org 12 September 2014 | Volume 9 | Issue 9 | e107911
